Browse By Region
Browse By Category
Recent News
By Region: North America
Firm Sought “Overwhelming” Profit For Smallpox Drug
(GSN Daily News) U.S. government health officials involved in negotiating a contract for a smallpox antiviral were taken aback by the high drug price sought by a pharmaceutical company whose leading shareholder has links to the Democratic Party and the Obama administration, CNN reported on Friday (see GSN, Nov. 28). SIGA Technologies in May received Read More »
- December 12, 2011
- | Filed under North America, Countermeasures, and Policy & Initiatives
Statement from Siga
(CNN) Republican and Democratic administrations, biodefense policy experts, and the broad scientific community have all agreed that smallpox is and remains a material threat to US national security. Smallpox is lethal, easy to grow …
- December 9, 2011
- | Filed under North America, Countermeasures, and Policy & Initiatives
World Bank funds health project into second phase
(Scoop.co.nz) The World Bank has granted Massey University $5m in funding to extend its education programme strengthening Asian public health and veterinary capacity to combat zoonotic diseases. In the first phase of the programme that has just completed, 67 health professionals from India, Pakistan, Sri Lanka, Bangladesh, Afghanistan and Nepal were trained in One Health Read More »
- December 9, 2011
- | Filed under North America, Agriculture, International, Policy & Initiatives, and Public Health
Biological weapons threat is growing, US warns
(Reuters) The United States called on Wednesday for closer international cooperation to prevent terrorist groups from developing or using biological weapons, a threat it said was growing. Secretary of State Hillary Clinton said countries must strengthen their ability to detect and respond to suspicious outbreaks of infectious disease that could be caused by pathogens falling Read More »
- December 9, 2011
- | Filed under Europe, North America, Biological Weapons, International, and Policy & Initiatives
Green Light for Boston Biolab?
(Scientist) After that, the agency says it will consider issuing the final approval for the lab to begin biosafety level-2 research, which involves “agents that pose moderate hazards to personnel and the environment,” according to the federal government’s …
- December 9, 2011
- | Filed under North America, Biosafety, and Research